Literature DB >> 31663046

Treatment of degenerative spondylolisthesis by instrumented posterolateral versus instrumented posterolateral with transforaminal lumbar interbody single-level fusion.

Jason P Kelly1, Christopher Alcala-Marquez1, John M Dawson1, Amir A Mehbod1, Manuel R Pinto1.   

Abstract

BACKGROUND: The purpose of this study was to compare outcomes of patients with degenerative spondylolisthesis treated by posterolateral lumbar fusion (PLF) versus PLF with transforaminal lumbar interbody fusion (PLF + TLIF). Studies of PLF versus PLF + TLIF have shown either equivalence or support for PLF + TLIF in lumbar spine surgery. Many are heterogeneous in the conditions treated, with few considering only spondylolisthesis of degenerative origin. Radiographic outcomes tend to favor PLF + TLIF, but this has not translated into better clinical outcomes.
METHODS: This was a retrospective cohort study. Forty-nine patients undergoing single-level PLF and seventy patients undergoing single-level PLF + TLIF with two-year follow-up were retrospectively reviewed. Demographics, Oswestry Disability Index (ODI), implant cost, surgical data, and complications were analyzed.
RESULTS: There was no difference in ODI improvement at two-year follow-up between the cohorts (P=0.97). Dural tears were more common in the PLF cohort (P<0.01), but otherwise complication and reoperation rates were similar. Implant cost (P<0.01) and operative time (P=0.01) were higher in the PLF + TLIF cohort.
CONCLUSIONS: The addition of a TLIF to a PLF did not result in a functional improvement in the treatment of degenerative spondylolisthesis as measured by the ODI. 2019 Journal of Spine Surgery. All rights reserved.

Entities:  

Keywords:  Degenerative spondylolisthesis; outcome; posterolateral lumbar fusion (PLF); transforaminal lumbar interbody fusion (TLIF)

Year:  2019        PMID: 31663046      PMCID: PMC6787357          DOI: 10.21037/jss.2019.08.09

Source DB:  PubMed          Journal:  J Spine Surg        ISSN: 2414-4630


  25 in total

1.  Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis.

Authors:  James N Weinstein; Jon D Lurie; Tor D Tosteson; Brett Hanscom; Anna N A Tosteson; Emily A Blood; Nancy J O Birkmeyer; Alan S Hilibrand; Harry Herkowitz; Frank P Cammisa; Todd J Albert; Sanford E Emery; Lawrence G Lenke; William A Abdu; Michael Longley; Thomas J Errico; Serena S Hu
Journal:  N Engl J Med       Date:  2007-05-31       Impact factor: 91.245

Review 2.  Spondylolisthesis and spondylolysis.

Authors:  Serena S Hu; Clifford B Tribus; Mohammad Diab; Alexander J Ghanayem
Journal:  J Bone Joint Surg Am       Date:  2008-03       Impact factor: 5.284

3.  Posterolateral lumbar fusion versus transforaminal lumbar interbody fusion for the treatment of degenerative lumbar scoliosis.

Authors:  Fang-cai Li; Qi-xin Chen; Wei-shan Chen; Kan Xu; Qiong-hua Wu; Gang Chen
Journal:  J Clin Neurosci       Date:  2013-07-01       Impact factor: 1.961

4.  Transforaminal lumbar interbody fusion (TLIF) versus posterolateral instrumented fusion (PLF) in degenerative lumbar disorders: a randomized clinical trial with 2-year follow-up.

Authors:  Kristian Høy; Cody Bünger; Bent Niederman; Peter Helmig; Ebbe Stender Hansen; Haisheng Li; Thomas Andersen
Journal:  Eur Spine J       Date:  2013-04-13       Impact factor: 3.134

5.  Differentiating minimum clinically important difference for primary and revision lumbar fusion surgeries.

Authors:  Leah Y Carreon; Kelly R Bratcher; Chelsea E Canan; Lauren O Burke; Mladen Djurasovic; Steven D Glassman
Journal:  J Neurosurg Spine       Date:  2012-11-16

6.  Surgical compared with nonoperative treatment for lumbar degenerative spondylolisthesis. four-year results in the Spine Patient Outcomes Research Trial (SPORT) randomized and observational cohorts.

Authors:  James N Weinstein; Jon D Lurie; Tor D Tosteson; Wenyan Zhao; Emily A Blood; Anna N A Tosteson; Nancy Birkmeyer; Harry Herkowitz; Michael Longley; Lawrence Lenke; Sanford Emery; Serena S Hu
Journal:  J Bone Joint Surg Am       Date:  2009-06       Impact factor: 5.284

7.  Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.

Authors:  Nan-Fu Chen; Zachary A Smith; Eric Stiner; Sean Armin; Hormoz Sheikh; Larry T Khoo
Journal:  J Neurosurg Spine       Date:  2010-01

8.  A Randomized, Controlled Trial of Fusion Surgery for Lumbar Spinal Stenosis.

Authors:  Peter Försth; Gylfi Ólafsson; Thomas Carlsson; Anders Frost; Fredrik Borgström; Peter Fritzell; Patrik Öhagen; Karl Michaëlsson; Bengt Sandén
Journal:  N Engl J Med       Date:  2016-04-14       Impact factor: 91.245

9.  Laminectomy plus Fusion versus Laminectomy Alone for Lumbar Spondylolisthesis.

Authors:  Zoher Ghogawala; James Dziura; William E Butler; Feng Dai; Norma Terrin; Subu N Magge; Jean-Valery C E Coumans; J Fred Harrington; Sepideh Amin-Hanjani; J Sanford Schwartz; Volker K H Sonntag; Fred G Barker; Edward C Benzel
Journal:  N Engl J Med       Date:  2016-04-14       Impact factor: 91.245

10.  A Randomized Controlled Trial Comparing Transforaminal Lumbar Interbody Fusion and Uninstrumented Posterolateral Fusion in the Degenerative Lumbar Spine.

Authors:  Kourosh Jalalpour; Pavel Neumann; Christer Johansson; Rune Hedlund
Journal:  Global Spine J       Date:  2015-03-25
View more
  2 in total

Review 1.  Degenerative Spondylolisthesis: A Narrative Review.

Authors:  Ibrahim Akkawi; Hassan Zmerly
Journal:  Acta Biomed       Date:  2022-01-19

2.  Augmenting posterolateral fusion with transforaminal lumbar interbody fusion cage improves clinical outcome, but not fusion rate, of posterior decompression.

Authors:  Teoman Atici; Selcan Yerebakan; Cenk Ermutlu; Ali Özyalçın
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.